National Bank of Canada FI Purchases Shares of 44,825 Masimo Co. (NASDAQ:MASI)

National Bank of Canada FI bought a new position in Masimo Co. (NASDAQ:MASI - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 44,825 shares of the medical equipment provider's stock, valued at approximately $5,218,000. National Bank of Canada FI owned 0.08% of Masimo as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Roubaix Capital LLC purchased a new stake in shares of Masimo in the second quarter worth $3,128,000. Versor Investments LP purchased a new stake in Masimo in the 2nd quarter worth $665,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Masimo by 8.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,877 shares of the medical equipment provider's stock valued at $992,000 after acquiring an additional 610 shares during the period. Raymond James Trust N.A. lifted its position in shares of Masimo by 14.3% in the second quarter. Raymond James Trust N.A. now owns 6,414 shares of the medical equipment provider's stock valued at $808,000 after acquiring an additional 800 shares in the last quarter. Finally, Fifth Third Bancorp boosted its stake in shares of Masimo by 16.4% in the second quarter. Fifth Third Bancorp now owns 695 shares of the medical equipment provider's stock worth $88,000 after acquiring an additional 98 shares during the period. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Masimo Stock Up 3.3 %

Shares of MASI stock traded up $3.63 during mid-day trading on Tuesday, hitting $114.99. The stock had a trading volume of 681,383 shares, compared to its average volume of 648,003. The firm has a market capitalization of $6.12 billion, a P/E ratio of 78.22 and a beta of 0.98. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.15. Masimo Co. has a 12-month low of $75.22 and a 12-month high of $153.93. The firm's 50-day moving average is $114.51 and its two-hundred day moving average is $125.90.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, topping analysts' consensus estimates of $0.77 by $0.09. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The company had revenue of $496.30 million during the quarter, compared to the consensus estimate of $493.92 million. During the same quarter in the previous year, the firm posted $0.62 earnings per share. Masimo's revenue for the quarter was up 9.0% compared to the same quarter last year. On average, analysts predict that Masimo Co. will post 3.87 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a report on Wednesday, August 7th. Piper Sandler boosted their target price on shares of Masimo from $160.00 to $165.00 and gave the stock an "overweight" rating in a report on Wednesday, August 7th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $144.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.